TEVA PHARMACEUTICAL INDUSTRIES LTD - SPONSORED ADS (TEVA)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q2 2024
609M
Holdings value Q2 2024
$9.89B
Value change Q2 2024
+$638M
Grand Portfolio weight change Q2 2024
+0.001%
Number of holders
523
Number of buys Q2 2024
68
Number of sells Q2 2024
-48
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 27.2M $491M +$51M $18.02 140
2024 Q2 609M $9.89B +$638M $16.25 526
2024 Q1 571M $8.05B -$55.6M $14.11 477
2023 Q4 578M $6.08B +$252M $10.44 436
2023 Q3 553M $5.64B +$644M $10.20 424
2023 Q2 494M $3.73B -$615M $7.53 416
2023 Q1 559M $4.94B -$37.3M $8.85 427
2022 Q4 546M $4.98B -$17.5M $9.12 410
2022 Q3 560M $4.51B +$431M $8.07 395
2022 Q2 505M $3.8B -$47M $7.52 422
2022 Q1 514M $4.83B +$15.2M $9.39 419
2021 Q4 505M $4.04B -$275M $8.01 403
2021 Q3 527M $5.13B -$316M $9.74 409
2021 Q2 560M $5.55B -$131M $9.90 425
2021 Q1 572M $6.6B +$11.4M $11.54 433
2020 Q4 569M $5.48B +$45M $9.65 426
2020 Q3 567M $5.1B -$199M $9.01 423
2020 Q2 579M $7.12B +$325M $12.33 437
2020 Q1 554M $4.97B -$440M $8.98 432
2019 Q4 587M $5.75B -$3.73M $9.80 409
2019 Q3 593M $4.08B -$372M $6.88 389
2019 Q2 640M $5.9B -$440M $9.23 438
2019 Q1 671M $10.5B -$197M $15.68 500
2018 Q4 683M $10.5B +$645M $15.42 528
2018 Q3 637M $13.7B -$681M $21.54 554
2018 Q2 667M $16.2B -$63.3M $24.32 538
2018 Q1 671M $11.5B +$1.34B $17.09 509
2017 Q4 589M $11.2B +$968M $18.95 507
2017 Q3 536M $9.43B -$1.11B $17.60 519
2017 Q2 588M $19.5B +$429M $33.22 643
2017 Q1 577M $18.5B +$220M $32.09 680
2016 Q4 596M $21.6B +$614M $36.25 726
2016 Q3 568M $26.1B -$1.25B $46.01 784
2016 Q2 595M $29.9B -$270M $50.23 804
2016 Q1 600M $32.1B -$614M $53.51 829
2015 Q4 610M $40B +$4.74B $65.64 870
2015 Q3 521M $29.4B +$663M $56.46 812
2015 Q2 513M $30.3B -$417M $59.10 809
2015 Q1 522M $32.5B +$477M $62.30 815
2014 Q4 517M $29.7B +$762M $57.51 813
2014 Q3 500M $26.9B +$666M $53.75 763
2014 Q2 487M $25.5B +$620M $52.42 771
2014 Q1 472M $24.9B +$1.02B $52.84 765